Research and therapeutic innovation for cardiovascular diseases are primary areas of excellence and focus at Barts and The London, QMUL where we have multiple programme grants, fellowships and projects.
Our position as one of the top cardiovascular research hubs in the UK is facilitated by close associations with the Heart Centre of Barts Health NHS Trust, serving six million people across North and East London, and reflected by awards from diverse funders including the National Institute for Health Research (NIHR).
£6.5m was awarded by the NIHR to establish a cardiovascular Biomedical Research Centre (BRC), providing an integrated discovery science and treatment centre in the heart of London. World-leading experts focus on inherited heart disease to address unmet clinical need, and by partnering with the technology industry and other academics from across the globe, the BRC will also encourage the development of new medical devices that will improve and save lives.
An award from the European Regional Development Fund has helped establish our ‘one stop’ innovation and development hub for new cardiovascular devices. The centre, which is the only one like it in the world, will offer new partnerships and a closer working relationship with industry to test ideas. It will be a place where clinicians work with bioengineers to solve problems together and take innovative ideas from concept to first human clinical trials.
We have established a close working relationship with the UK’s major funder of cardiovascular research, the British Heart Foundation (BHF) with several programmes, projects and fellowships. Our Professor Federica Marelli-Berg is the official BHF Professor of Cardiovascular Immunology, due to her leading work in the role that inflammation plays in cardiovascular disease.
Additionally, Barts and The London, QMUL runs the BHF’s doctoral training programme in Cardiovascular Inflammation.